Nancy S Moua, NP
Nurse Practitioner · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Infusion Express of California Inc · 24 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Nancy S Moua’s office at (408) 854-5566 to ask if they take your plan before you enroll.
Original Medicare doctor bills
$42,081
Medicare paid this office $42,081 for 16 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Injection of drug or substance under skin or into muscle | 14 | $228 | $12 |
Who their Medicare patients are
16 Original Medicare patients in 2024. Average age 78 · Under 65 0% · Health risk score 0.94. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
The office billed $148,918, Medicare allowed $54,388 and paid $42,081; for 2,954 services of 11 kinds; $41,469 of it was for drugs given in the office and $612 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 16 | 2,954 | 78 | 0.94 | $148,918 | $42,081 |
| 2023 | 131 | 68,665 | 76 | 1.00 | $3,415,085 | $984,758 |
| 2022 | 79 | 38,671 | 75 | 1.08 | $2,530,479 | $710,424 |
| 2021 | 29 | 16,950 | 74 | 1.55 | $1,626,119 | $466,658 |
| 2020 | 73 | 10,979 | 76 | 1.54 | $2,519,358 | $1,157,499 |
| 2019 | 89 | 5,848 | 76 | 1.47 | $2,319,865 | $335,219 |
| 2018 | 31 | 318 | 76 | 1.32 | $121,495 | $18,831 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Injection, omalizumab, 5 mg | 14 | $233,588 | None |
| Injection, inclisiran, 1 mg | 25 | $93,190 | None |
| Injection, denosumab, 1 mg | 43 | $55,746 | None |
| Injection of drug or substance under skin or into muscle | 111 | $5,468 | $12 |
| Administration of chemotherapy into vein, 1 hour or less | 12 | $2,891 | $120 |
2022: 3 services
| Injection, denosumab, 1 mg | 25 | $33,749 | None |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 11 | $5,872 | $61 |
| Injection of drug or substance under skin or into muscle | 62 | $3,437 | $12 |
2021: 1 service
| Injection of drug or substance under skin or into muscle | 20 | $1,978 | $12 |
2020: 5 services
| Extended office or other outpatient service, first hour | 59 | $24,900 | $101 |
| Return visit (30+ min) | 59 | $21,489 | $87 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 66 | $19,685 | $63 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 63 | $9,323 | $19 |
| Test to measure exhaled air for evaluation of lung function at rest | 31 | $3,046 | $46 |
2019: 6 services
| Extended office or other outpatient service, first hour | 76 | $105,774 | $100 |
| Return visit (30+ min) | 76 | $91,955 | $87 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 76 | $66,760 | $63 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 76 | $38,695 | $18 |
| Test to measure exhaled air for evaluation of lung function at rest | 57 | $25,286 | $48 |
| New patient visit (45+ min) | 48 | $6,234 | $130 |
2018: 4 services
| Extended office or other outpatient service, first hour | 25 | $6,262 | $101 |
| Return visit (30+ min) | 25 | $5,067 | $86 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 25 | $3,942 | $65 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 25 | $2,286 | $19 |
Medicaid work
$56 in 2020
Medicaid paid $56 for 619 billed services this clinician did in 2020, up to 33 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour | 146 | $18 |
| Prolonged service(s) in the outpatient setting requiring direct patient contact beyond the time of the usual service; first hour (List separately in addition to code for outpatient Evaluation and Management or psychotherapy service, except with office or other outpatient services [99202, 99203, 99204, 99205, 99212, 99213, 99214, 99215]) | 146 | $15 |
| Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure) | 146 | $11 |
| Return visit (30+ min) | 146 | $11 |
| Oxygen uptake, expired gas analysis; rest, indirect (separate procedure) | 15 | $0 |
| SBSQ NURSING FACILITY CARE SF MDM 10 MINUTES | 20 | $0 |
| 2020 | 619 | 6 | 33 | $56 |
Money from drug and device companies
$45 in 2025
| 2025 | 1 | 2 | None | $45 |
| 2023 | 1 | 1 | None | $25 |
| 2022 | 2 | 3 | None | $171 |
| 2021 | 4 | 5 | None | $200 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Lundbeck | Vyepti | $45 | 2 payments
|
See all 2 published payments
| Lundbeck | Meals · 2025-12-09 | Vyepti | $23 |
| Lundbeck | Meals · 2025-09-04 | Vyepti | $22 |
See earlier years (2023, 2022, 2021)
2023: $25
| Lundbeck | Vyepti | $25 | 1 payment
|
2022: $171
| Genentech USA | Ocrevus | $137 | 1 payment
|
| GlaxoSmithKline | Nucala | $34 | 2 payments
|
2021: $200
| GlaxoSmithKline | Nucala | $125 | 1 payment
|
| Horizon Therapeutics plc | Tepezza | $37 | 2 payments
|
| Biogen | None | $25 | 1 payment
|
| Grifols USA | Gamunex-C | $13 | 1 payment
|
Professional record
- NPI
- 1144744616
- Licence
- CA 95003432
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 670 N Mccarthy Blvd Ste 220, Milpitas, CA, 95035
- NPI first listed
- 2017-07-27
- NPI last updated
- 2022-07-21
This is when the NPI record was last certified, not a medical board exam.